Valuation: Novartis AG

Market Cap 295B 259B 241B 221B 416B 28,438B 422B 2,864B 1,119B 13,981B 1,109B 1,085B 48,339B P/E 2026 *
21.6x
P/E 2027 * 18.9x
Enterprise Value 328B 288B 268B 246B 463B 31,627B 470B 3,185B 1,244B 15,549B 1,233B 1,206B 53,760B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 5.29x
Free-Float
91.66%
Yield 2026 *
2.81%
Yield 2027 * 2.94%
1 day+1.80%
1 week+4.40%
Current month+1.53%
1 month+1.84%
3 months+12.66%
6 months+10.30%
Current year+17.26%
1 week 121.68
Extreme 121.68
129.4
1 month 121.06
Extreme 121.06
129.4
Current year 107.68
Extreme 107.68
131
1 year 91.56
Extreme 91.56
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.28%+4.40%+37.69%+41.62% 295B
+0.27%+4.32%+48.05%+162.96% 1,067B
+1.66%+7.52%+60.95%+54.03% 635B
+0.40%+2.55%+37.84%+74.57% 458B
+1.41%+8.56%+38.18%+32.17% 347B
+1.72%+4.10%+19.44%+20.45% 262B
+1.84%-0.46%-27.63%-38.65% 216B
+0.61%+3.75%+25.41%+60.07% 203B
+1.88%-1.42%+16.18%+71.64% 161B
+1.04%+0.04%+1.85%-31.60% 140B
Average +1.33%+0.99%+25.80%+44.72% 378.34B
Weighted average by Cap. +1.10%+1.80%+36.69%+74.54%

Financials

2026 *2027 *
Net sales 57.55B 50.55B 47.01B 43.14B 81.05B 5,542B 82.3B 558B 218B 2,725B 216B 211B 9,421B 61.09B 53.66B 49.9B 45.79B 86.04B 5,883B 87.37B 593B 232B 2,893B 229B 224B 10,001B
Net income 13.94B 12.24B 11.38B 10.45B 19.63B 1,342B 19.93B 135B 52.81B 660B 52.32B 51.19B 2,281B 15.34B 13.48B 12.53B 11.5B 21.61B 1,477B 21.94B 149B 58.14B 726B 57.6B 56.35B 2,511B
Net Debt 33.11B 29.08B 27.05B 24.82B 46.63B 3,189B 47.35B 321B 125B 1,568B 124B 122B 5,421B 27.82B 24.43B 22.72B 20.85B 39.17B 2,679B 39.78B 270B 105B 1,317B 104B 102B 4,554B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
27/07/26 CHF 128.52 +1.28% 2,435,055
24/07/26 CHF 126.90 -0.60% 1,859,367
23/07/26 CHF 127.66 +1.85% 2,482,939
22/07/26 CHF 125.34 -0.16% 2,648,334
21/07/26 CHF 125.54 +1.98% 3,462,607
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
155.36USD
Average target price
154.07USD
Spread / Average Target
-0.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock